Literature DB >> 3050944

Hypersensitivity reaction with intravenous GnRH after pulsatile subcutaneous GnRH treatment in male hypogonadotrophic hypogonadism.

V Popović1, Z Milosević, R Djukanović, D Micić, M Nesović, D Manojlović, P Djordjević, J Mićić.   

Abstract

Chronic pulsatile subcutaneous administration of low doses of gonadotrophin releasing hormone (GnRH) is an effective therapy for men with hypogonadotrophic hypogonadism. Hypersensitivity reactions to GnRH are rare. We wish to report hypersensitivity reactions with intravenous GnRH after low dose subcutaneous pulsatile GnRH treatment in two men with hypogonadotrophic hypogonadism due to suprasellar disease.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3050944      PMCID： PMC2428843          DOI： 10.1136/pgmj.64.749.245

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  3 in total

1.  Induction of male puberty by long-term pulsatile subcutaneous LH-RH therapy.

Authors:  G Skarin; S J Nillius; G Ahlsten; T Tuvemo; L Wide
Journal:  Ups J Med Sci       Date:  1984       Impact factor: 2.384

2.  Events surrounding the initiation of puberty with long term subcutaneous pulsatile gonadotropin-releasing hormone in a female patient with Kallman's syndrome.

Authors:  M M Seibel; P Claman; S P Oskowitz; C McArdle; F G Weinstein
Journal:  J Clin Endocrinol Metab       Date:  1985-09       Impact factor: 5.958

3.  Pulsatile gonadotropin-releasing hormone therapy in male patients with Kallmann's syndrome or constitutional delay of puberty.

Authors:  J Happ; W Ditscheid; U Krause
Journal:  Fertil Steril       Date:  1985-04       Impact factor: 7.329
  3 in total
  1 in total

1.  Hypersensitivity reaction to intranasal gonadotropin-releasing hormone.

Authors:  J Mayr; R Aigner
Journal:  Eur J Pediatr       Date:  1995-03       Impact factor: 3.183
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.